ArticleTranslational lung cancer research2020

Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.

Xuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.